4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-21-006141
Chief Financial Officer bought 5,000 shares at $0.94 ($4,702)
From the SEC's structured data for this filing
Trades in this filing
Downs Christopher · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-12-06 | Purchase : show line 1 in the form | +5,000 | $0.94 | $4,702 | 151,500 | D |
| Open-market purchases · 5,000 sh · avg $0.94 · $4,702 | ||||||
Loading xslF345X03/ownership.xml…